References
- Lewis JR, Zomepirac sodium, a new nonaddicting analgesic. J Am Med Assoc. 1981; 246: 377–9.
- Cooper SA, Reynolds DC, Kruger GO, Gottlieb S. An analgesic relative potency assay comparing zomepirac sodium and aspirin. J Clin Pharmacol. 1980; 20: 98–106.
- Mayer TG, RuofT GE. Clinical evaluation of zomepirac in the treatment of acute orthopedic pain. J Clin Pharmacol. 1980; 20: 285–91.
- de Andrade JR, Honig S, Ciccone WJ, Leffall L. Clinical comparison of zomepirac with pentazocine in the treatment of postoperative pain. J Clin Pharmacol. 1980; 20: 292–7.
- Stambaugh JE, Tejada F, Trudnowski RJ. Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain. J Clin Pharmacol. 1980; 20: 261–70.
- Honig S. Preliminary report: Long-term safety of zomepirac. J Clin Pharmacol. 1980; 20: 392–96.
- Mc Carthy JT, Schwartz GL, Blair TJ, Pierides AM, Van Den Berg CJ. Reversible Nonoliguric Acute Renal Failure associated with zomepirac therapy. Mayo Clin Proc. 1982; 57: 351–4.
- Altman RD, Johnston CC, Khairi MRA, Wellman H, Serafini AN, Sankey RR. Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (osteitis deformans). N Engl J Med. 1973; 289: 1379–84.
- Nagant de Deuxchaines C, Maldague B, Malghem J, Devogelaer JP, Huaux JP, RomboutsLindemans C. The action of the main therapeutic regimes on Paget’s disease of bone, with a note on the effect of vitamin D deficiency. Arthritis and Rhumatism. 1980; 23: 1215–34.
- Hosking DJ, Bijvoet OLM, van Aken J, Will EJ. Paget’s bone disease treated with diphosphonate and calcitonin. Lancet. 1976; 1:615–7.
- Sannerstedt R, Brorson L, Berglund G, Werko L. Minoxidil haemodynamic and clinical experiences with a new peripheral vasodilator. Acta Med Scand. 1975; 197: 409–14.
- Pettinger WA. Minoxidil and the treatment of severe hypertension. N Engl J Med. 1980* 303: 922–6.
- Feroli ER, Jr. Minoxidil. Johns Hopkins Med J. 1981; 149: 188–91.
- De Meyer M, Pirson Y, SquilTlet JP, De Plaen JF, van Ypersele de Strihou C, Alexandre GPJ. Traitement par le minoxidil de I’hypcrtension arterielle rebelle apres transplantation renale. Nephrologie. 1983; 4: 10–3.
- Houston MC, McChesney JA, Chatterjee K. Pericardial Effusion Associated With Minoxidil Therapy. Arch hit Med. 1981; 141 69–71.
- Graf KJ, Neumann F, Horowski R. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats. Endocrinology. 1976; 98: 598–605.
- Giulani L, Barneca T, Giberti C et al. Clinical effects of a prolactin-inhibiting drug, lisuride, in patients with benign prostatic hypertrophy Curr Tlterap Res. 1982; 32: 8–16.
- Gopinathan G, Teravainen H, Dambrosia JM et al., Lisuride in parkinsonism. Neurology 1981; 31: 371–6.
- De Cecco L, Venturini PL, Ragni N et al. Effect of Lisuride on inhibition of lactation and serum prolactin. Brit J Obst Gvnaecol. 197986: 905–8.
- Chiodini P, Liuzzi A, Cozzi R. et al. Size Reduction of Macropolactinomas by Bromocriptine or Lisuride Treatment. J Clin Endocrinol Metab. 1981; 53: 737–43.
- Liebcrman A, Goldstein M, Neophytides A et al. Lisuride in Parkinson disease: Efficacy of lisuride compared to levodopa. Neurologv 1981; 31: 961–5.